Champion Safe Highlights Explosive 92% Year-to-Date Growth at SafeSource Pennsylvania

(NASDAQ:AREB),(NASDAQ:AREBW), Acquisition of Champion's Lewisberry, PA Location Drives Major Expansion for Northeast Retailer Provo, UT, Nov. 13, 2025 (GLOBE NEWSWIRE) — Champion Safe Company (championsafe.com), a premier manufacturer of high-security safes and a proud subsidiary of American Rebel Holdings, Inc. (NASDAQ: AREB), America's Patriotic Brand, proudly recognizes SafeSource USA for its outstanding 92% year-to-date growth […]

Draganfly Secures Second Major Order from Fortune 50 Telecommunications Company to Expand NDAA-Compliant Heavy Lift Drone Fleet

(NASDAQ:DPRO),(Boerse Berlin – Freiverkehr:3U8A.BE),(CNSX:DPRO.CN),(Boerse Frankfurt – Freiverkehr:3U8A),(Frankfurt:3U8A.F),(CNSX:DPRO),(Boerse Frankfurt – Freiverkehr:3U8), Tampa Bay, Florida, Nov. 13, 2025 (GLOBE NEWSWIRE) — Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8A) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions and systems developer, today announced a second purchase order (“PO”) from a Fortune 50 telecommunications company. Under this agreement,

Tiziana Life Sciences to Present at Jefferies Global Healthcare Conference

(NASDAQ:TLSA), BOSTON, Nov. 13, 2025 (GLOBE NEWSWIRE) — Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, today announced that its senior leadership team will present at the prestigious Jefferies London Healthcare Conference. Chief

Fate Therapeutics Reports Third Quarter 2025 Financial Results and Business Updates

(NasdaqGM:FATE), Authorization Received from UK and EU Authorities to Activate ex-US Clinical Trial Sites Supporting the Ongoing Patient Enrollment of FT819, an Off-the-Shelf CD19-targeted CAR T-cell Product Candidate that Utilizes Less-intensive or No Conditioning, Enabling Broad Patient Accessibility First Systemic Sclerosis Patient treated in Phase 1 Study of FT819 Following Fludarabine-free Conditioning; Dose Expansion Designed

AEON Biopharma Announces Fundraise Totaling Up to ~$22 Million through Private Placement and Proposed Exchange of Daewoong Convertible Notes

– Combined transactions will strengthen balance sheet and reduce outstanding debt by more than 90% – – $6 million PIPE financing with potential for over $7 million of additional capital via cash-exercise warrants – – Daewoong has entered binding term sheet for exchange of $15 million of notes plus accrued interest into equity, $1.5 million

Amaze Partners with Jedari to Bring Integrated E-Commerce Experience to Musicians

(NYSE MKT:AMZE), NEWPORT BEACH, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) — Amaze Holdings, Inc. (NYSE American: AMZE) (“Amaze”) a global leader in creator-powered commerce, today announced a strategic partnership with Jedari Technology, Inc., a leading platform in community-driven technology solutions for musicians, artists, creators, and brands. Through this collaboration, Amaze's integrated AI framework, Amaze Moments,

AEON Biopharma Reports Positive and Robust Biosimilarity Results: Identical Amino Acid Sequence and Highly Similar Functional Analysis Data

– 100% match of visible amino acid sequence confirmed between ABP-450 and BOTOX(R) – – Functional assays demonstrate strong similarity in potency and composition, with directionally consistent enzymatic activity results – IRVINE, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) — AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE American: AEON), a biopharmaceutical company seeking an accelerated

VisionWave Enters LOI to Acquire BladeRanger Subsidiary, Expanding AI-Driven Drone Capabilities for Security, Infrastructure, and Emergency Response

(NasdaqGM:VWAV),(NasdaqGM:VWAVW),(TASE:BLRN.TA),(TASE:BLRN), WEST HOLLYWOOD, Calif. and RAMAT EFAL, Israel, Nov. 13, 2025 (GLOBE NEWSWIRE) — VisionWave Holdings, Inc. (Nasdaq: VWAV) (“VisionWave” or the “Company“) today announced that it has signed a binding Letter of Intent (“LOI”) to acquire Solar Drone Ltd., a subsidiary of BladeRanger Ltd. (TASE: BLRN) and a developer of mission-ready unmanned-aerial systems designed

Aduro Clean Technologies to be Featured on “Earth with John Holden”

(CNSX:ACT.CN),(OTC US:ACTHF),(Other OTC:ACTHF),(Boerse Frankfurt – Freiverkehr:9D5),(NASDAQ:ADUR), LONDON, Ontario, Nov. 13, 2025 (GLOBE NEWSWIRE) — Aduro Clean Technologies Inc. (“Aduro” or the “Company“) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower-value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st century,

MoonLake Immunotherapeutics Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – MLTX

(NASDAQ:MLTX), LOS ANGELES, Nov. 13, 2025 (GLOBE NEWSWIRE) — The DJS Law Group reminds investors of a class action lawsuit against MoonLake Immunotherapeutics (“MoonLake” or “the Company”) (NASDAQ: MLTX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders

Scroll to Top